The EU Directive for Clinical Trials requests for a pharmaceutical company intending to perform clinical trials in the EU to either be established in the EU or represented by a so called “legal representative”.
National legislation of some EU member states demands that for clinical investigations with medical devices there must either be a sponsor in the EU or the sponsor must assign an EU representative.